Pharmaceutical Technology on AST’s Latest Aseptic Fill-Finish Solution
Josh Russell, AST Vice President of Sales & Marketing, sat down with Pharmaceutical Technology at Interphex 2024 to discuss recent developments and advancements at AST,
Isolator Air Handling: Advancements and Considerations for Fill-Finish Processing
In the fill-finish manufacturing of parenteral liquid pharmaceuticals, maintaining product sterility is paramount. The choice of what kind of barrier technology to utilize becomes key,
The Quest for Sterility Assurance: A New Approach to Isolator Decontamination
One of the more challenging, essential aspects of planning for an isolated fill-finish operation is determining the approach to decontamination. Sterility assurance is a top priority, and ensuring a selected method meets regulatory thresholds is vital.
The Next-Generation Isolator: A User-Friendly Solution for Fill-Finish Professionals
When AST came to the table on the design for our new fill-finish isolator, one of the first areas AST engineers wanted to address was
AST Perspectives: Reimagining Fill-Finish Isolator Design
By Steven Ng, CTO & VP of Customer Service This past October, AST announced a groundbreaking collaboration with Germfree on a new fill-finish isolator. This
Toolless Change Parts: A Flexible Solution
Aseptic fill-finish professionals are continually looking to augment their approach to a market that continues to grow and reflect innovations happening around sterile parenteral treatments.
AST Perspectives: Looking Towards a Fill-Finish Future Rooted in American Ingenuity
A Word from AST President & CEO Joe Hoff It’s common practice at AST to revisit our Mission Statement as we go about our work
Ready and Sealed: The RTU Advantage for Optimal Vial Sealing
For small-batch, high-value drug products, the aseptic advantages of pre-sterilized ready-to-use vials are clear. To realize the full scope of benefits that RTU vials can
Technology Transfer Strategies: Fill-Finish Automation and Robotics
Throughout the lifecycle of a drug product, many critical target points for optimization make all the difference in the time-to-market equation. A holistic approach to
Preparing for the Small Batch Revolution: Identifying Successful Biopharmaceutical Partnerships
Small-batch manufacturing of liquid pharmaceuticals is slated for exponential growth in the coming years and represents exciting possibilities for the future of medicine and personalized